Telemetry Investments’s Novavax NVAX Stock Holding History

Telemetry Investments’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-100,000	Closed	-$586K	–	62
2019 Q2	$586K	Buy	+100,000	New	+$787K	0.45%	39
2019 Q1	–	Sell	-1,630	Closed	-$60K	–	133
2018 Q4	$60K	Sell	1,630 -6,870	-81%	-$266K	0.04%	129
2018 Q3	$320K	Buy	+8,500	New	+$239K	0.15%	76
2018 Q2	–	Sell	-5,000	Closed	-$210K	–	155
2018 Q1	$210K	Sell	5,000 -2,500	-33%	-$100K	0.08%	118
2017 Q4	$186K	Sell	7,500 -2,500	-25%	-$61K	0.07%	116
2017 Q3	$228K	Buy	+10,000	New	+$224K	0.08%	120

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HIG

Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Telemetry Investments's NVAX Position: Q4 2022 in Review

Telemetry Investments opened a new position in Novavax (NVAX) in Q4 2022: 17,632 shares worth $181K. The stake represents 0.29% of the portfolio and ranks #76 among its holdings.

253 funds tracked by Wall St. Rank hold NVAX as of Q4 2022.

Telemetry Investments held 17,632 shares of Novavax worth $181K as of Q4 2022.
Novavax was a new Telemetry Investments position in Q4 2022.
Novavax made up 0.29% of Telemetry Investments's portfolio in Q4 2022, its #76 holding.
253 funds tracked by Wall St. Rank held Novavax as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.